Quebec SEAO #20163121

Proficiency Testing Services for Pathology and Oncology Analyses for PEEQ 2027 (INSPQ)

The Institut national de santé publique du Québec (INSPQ) is planning to procure proficiency testing services for clinical pathology and oncology analyses as part of the 2027 provincial external quality assessment program (PEEQ). - Government Buyer: - Institut national de santé publique du Québec (INSPQ) - OEM/Vendor: - The College of American Pathologists (CAP) is the only named provider - Services Requested: - Proficiency testing for a range of specialized laboratory analyses, including: - FISH (Fluorescence In Situ Hybridization) on interphase nuclei for oncological rearrangement detection (fusion or separation probe) (Part #50719) - FISH in interphase (Part #50720) - FISH on paraffin-embedded tissue (any probe type) (Part #50729) - DNA mismatch repair proteins (MLH1, MSH2, MSH6, PMS2) for microsatellite instability (MSI-H) via immunohistochemistry (Part #60042) - Immunohistochemistry/cytochemistry with controls (Part #60151) - Immunohistochemical biomarkers for therapeutic purposes, per marker, including count (Part #60189) - Specific tumor markers (HER 2/neu) via immunohistochemistry, per marker, including count (Part #60570) - Breast and stomach cancer detection (ERBB2 or HER2/neu) via FISH, per marker, including count (Part #65008) - Detection of Kappa, Lambda light chains or EBV virus by chromogenic in situ hybridization (CISH) (Part #65160) - No specific quantities provided - Notable Requirements: - The College of American Pathologists is identified as the sole source following a market review - The contract is justified under Article 13 (4º) of the Law on Contracts of Public Bodies - The procurement may proceed as a direct negotiation unless other interested firms respond

Description

This procurement involves the supply of proficiency testing services for pathology and oncology analyses for the provincial external quality assessment program (PEEQ) for 2027. The contract is intended to be awarded to a specific provider identified after a market review, The College of American Pathologists. Interested firms must respond by August 21, 2026. The INSPQ will decide whether to launch a public tender or negotiate the contract directly, justified under Article 13 (4º) of the Law on Contracts of Public Bodies.

View original listing